Aeterna Zentaris Inc. (AEZS): Price and Financial Metrics

Aeterna Zentaris Inc. (AEZS)

Today's Latest Price: $1.20 USD

0.01 (-0.83%)

Updated Jan 27 4:00pm

Add AEZS to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 330 in Biotech

See all "A" rated Strong Buy stocks

AEZS Stock Summary

  • For AEZS, its debt to operating expenses ratio is greater than that reported by merely 0.37% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -53.89 for Aeterna Zentaris Inc; that's greater than it is for only 0.35% of US stocks.
  • As for revenue growth, note that AEZS's revenue has grown 4,832.29% over the past 12 months; that beats the revenue growth of 99.79% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Aeterna Zentaris Inc, a group of peers worth examining would be SHIP, PULM, CCUR, STML, and MFIN.
  • AEZS's SEC filings can be seen here. And to visit Aeterna Zentaris Inc's official web site, go to
AEZS Daily Price Range
AEZS 52-Week Price Range

AEZS Stock Price Chart More Charts

AEZS Price/Volume Stats

Current price $1.20 52-week high $5.57
Prev. close $1.21 52-week low $0.76
Day low $1.15 Volume 197,608
Day high $1.24 Avg. volume 268,217
50-day MA $0.95 Dividend yield N/A
200-day MA $1.98 Market Cap 24.04M

Aeterna Zentaris Inc. (AEZS) Company Bio

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. The company was founded in 1991 and is based in Summerville, South Carolina.

AEZS Latest News Stream

Event/Time News Detail
Loading, please wait...

AEZS Latest Social Stream

Loading social stream, please wait...

View Full AEZS Social Stream

AEZS Price Returns

1-mo 46.27%
3-mo 14.01%
6-mo -52.00%
1-year -66.94%
3-year -52.94%
5-year -97.74%
YTD 31.87%
2019 -69.05%
2018 24.58%
2017 -34.44%
2016 -19.64%
2015 -92.53%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6581 seconds.